Last reviewed · How we verify

NCT06047704

The Effect of State and Trait Anxiety on Pain-pressure Threshold

Completed Last updated 13 October 2023
What this trial tests

trial testing No intervention in Pain in 38 participants. Completed in 4 October 2023.

Timeline
28 July 2023
Primary endpoint
4 October 2023
4 October 2023

Quick facts

Lead sponsorPhiladelphia College of Osteopathic Medicine
StatusCompleted
Study typeOBSERVATIONAL
Enrollment38
Start date28 July 2023
Primary completion4 October 2023
Estimated completion4 October 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Philadelphia College of Osteopathic Medicine

Who can join

18 and older, any sex, with Pain or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to find out if different types of anxiety impact the sensation of how sensitive various muscles are to the application of pressure. This information can help researchers and healthcare providers better understand how people feel pain differently based on emotional factors This study is designed to study people who can be expected to have normal pain sensation processing

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Effect of State and Trait Anxiety on Pain-Pressure Threshold
    Lowe S, Downing K, Fair B, Hughey C. · · 2024 · DOI 10.21203/rs.3.rs-3848575/v1

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Philadelphia College of Osteopathic Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06047704.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing